Intrexon posts loss in quarter

Intrexon, of Germantown, a synthetic biology company, reported a net loss of nearly $53 million for the second quarter. Intrexon’s loss was $52.9 million, or 53 cents per share, compared with a net loss of $6.5 million, or $2.45 per share, for the prior-year period. Revenue was $11.8 million, an increase of 76 percent from $6.7 million in 2013’s second quarter. “Year to date, cash consideration from our channel collaborators has been more than sufficient to pay our cash operating expenses, while we have continued to build value in our portfolio of royalties and profits participation across multiple product candidates in development across various industries,” Intrexon CEO Randal J. Kirk said in a statement.

Leave a Reply

Your email address will not be published. Required fields are marked *